Cargando…
Effective Classification and Gene Expression Profiling for the Facioscapulohumeral Muscular Dystrophy
The Facioscapulohumeral Muscular Dystrophy (FSHD) is an autosomal dominant neuromuscular disorder whose incidence is estimated in about one in 400,000 to one in 20,000. No effective therapeutic strategies are known to halt progression or reverse muscle weakness and atrophy. It is known that the FSHD...
Autores principales: | González-Navarro, Félix F., Belanche-Muñoz, Lluís A., Silva-Colón, Karen A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3862578/ https://www.ncbi.nlm.nih.gov/pubmed/24349187 http://dx.doi.org/10.1371/journal.pone.0082071 |
Ejemplares similares
-
Cognitive profile of patients with facioscapulohumeral muscular dystrophy
por: dos Santos, Vanessa Brzoskowski, et al.
Publicado: (2021) -
Gene Editing to Tackle Facioscapulohumeral Muscular Dystrophy
por: Mariot, Virginie, et al.
Publicado: (2022) -
Characterizing the face in facioscapulohumeral muscular dystrophy
por: Loonen, T. G. J., et al.
Publicado: (2020) -
Treatment of facioscapulohumeral muscular dystrophy with Denosumab
por: Lefkowitz, Stanley S., et al.
Publicado: (2012) -
Sarcopenic Obesity in Facioscapulohumeral Muscular Dystrophy
por: Vera, Kathryn, et al.
Publicado: (2020)